| Jdee Ryan Wilson, MD | |
|
700 E Alice St, State Hospital South, Blackfoot, ID 83221 | |
| (208) 785-1200 | |
| (208) 785-8516 |
| Full Name | Jdee Ryan Wilson |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 700 E Alice St, Blackfoot, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598828816 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | M9137 (Idaho) | Primary |
| Entity Name | Mental Health Specialists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548585458 PECOS PAC ID: 1658665427 Enrollment ID: O20160802003169 |
News Archive
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.
A new study demonstrates that women in their third trimester are unlikely to pass a SARS-CoV-2 infection onto their babies.
At a roundtable organized by the Coalition for Innovation Employment and Development, the U.S.-India Business Council's 'Coalition for Healthy India' released the findings of its report on "The Value of Incremental Pharmaceutical Innovation: Benefits for Indian Patients and Indian Business". The report highlights and substantiates the impact of restrictive policies in India, with respect to medical and pharmaceutical innovation.
Keraderm Corp. announced the closing today of a $2.5 million dollar Series A investment by NewVa Capital Partners, LP. Currently starting clinical trials, the company's platform harnesses phototherapy technology to treat nail and skin infections. NewVa Capital Partners is a private equity and venture capital fund managed by Third Security, LLC and provides early stage investments in companies located or considering location in the NewVa region of southwest Virginia. This is Keraderm's first institutional investment round.
Adding functional skills training to cognitive remediation therapy significantly improves functional competence and real-world behavior in patients with schizophrenia, show study findings.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jdee Ryan Wilson, MD 700 E Alice St, State Hospital South, Blackfoot, ID 83221 Ph: (208) 785-1200 | Jdee Ryan Wilson, MD 700 E Alice St, State Hospital South, Blackfoot, ID 83221 Ph: (208) 785-1200 |
News Archive
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.
A new study demonstrates that women in their third trimester are unlikely to pass a SARS-CoV-2 infection onto their babies.
At a roundtable organized by the Coalition for Innovation Employment and Development, the U.S.-India Business Council's 'Coalition for Healthy India' released the findings of its report on "The Value of Incremental Pharmaceutical Innovation: Benefits for Indian Patients and Indian Business". The report highlights and substantiates the impact of restrictive policies in India, with respect to medical and pharmaceutical innovation.
Keraderm Corp. announced the closing today of a $2.5 million dollar Series A investment by NewVa Capital Partners, LP. Currently starting clinical trials, the company's platform harnesses phototherapy technology to treat nail and skin infections. NewVa Capital Partners is a private equity and venture capital fund managed by Third Security, LLC and provides early stage investments in companies located or considering location in the NewVa region of southwest Virginia. This is Keraderm's first institutional investment round.
Adding functional skills training to cognitive remediation therapy significantly improves functional competence and real-world behavior in patients with schizophrenia, show study findings.
› Verified 3 days ago
Dr. Kelly Page Palmer, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 700 East Alice Street, Blackfoot, ID 83221 Phone: 208-785-8517 Fax: 208-785-8516 | |
Andrew L Olnes, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 700 E Alice St, Blackfoot, ID 83221 Phone: 208-785-1200 Fax: 208-785-8516 |